Netflix (NASDAQ:NFLX – Get Free Report) had its price target upped by investment analysts at Rosenblatt Securities from $95.00 to $96.00 in a research note issued on Monday,MarketScreener reports. The firm presently has a “neutral” rating on the Internet television network’s stock. Rosenblatt Securities’ target price suggests a potential downside of 2.70% from the company’s […]

Unicycive Therapeutics (NASDAQ:UNCY – Get Free Report) had its price target decreased by equities research analysts at Benchmark from $21.00 to $15.00 in a research report issued on Monday,Benzinga reports. The firm presently has a “speculative buy” rating on the stock. Benchmark’s price target indicates a potential upside of 116.45% from the company’s previous close. […]

Netflix (NASDAQ:NFLX – Free Report) had its price target raised by President Capital from $133.00 to $134.00 in a report released on Tuesday,MarketScreener reports. They currently have a buy rating on the Internet television network’s stock. Other equities analysts have also recently issued reports about the company. Piper Sandler reaffirmed a “positive” rating and issued […]

PepsiCo (NASDAQ:PEP – Get Free Report) had its price target dropped by investment analysts at Deutsche Bank Aktiengesellschaft from $176.00 to $169.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective would suggest a potential upside of 7.19% from the company’s […]

Immix Biopharma (NASDAQ:IMMX – Get Free Report) had its target price raised by equities researchers at Mizuho from $14.00 to $15.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Mizuho’s target price indicates a potential upside of 80.27% from the company’s […]

Atossa Genetics (NASDAQ:ATOS – Get Free Report) had its price objective hoisted by equities researchers at HC Wainwright from $7.00 to $25.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 361.25% from the […]

Sutro Biopharma (NASDAQ:STRO – Get Free Report) had its price objective upped by stock analysts at Deutsche Bank Aktiengesellschaft from $51.00 to $55.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price would indicate a potential upside of 128.98% from the […]

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Get Free Report) had its target price hoisted by B. Riley Financial from $3.00 to $4.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. B. Riley Financial’s price target would suggest a potential upside of 147.68% from the company’s current […]